1. Home
  2. CODA vs MDXH Comparison

CODA vs MDXH Comparison

Compare CODA & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coda Octopus Group Inc.

CODA

Coda Octopus Group Inc.

N/A

Current Price

$8.90

Market Cap

98.9M

Sector

Industrials

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

N/A

Current Price

$3.15

Market Cap

167.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CODA
MDXH
Founded
1994
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
98.9M
167.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CODA
MDXH
Price
$8.90
$3.15
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
44.7K
137.0K
Earning Date
01-28-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
15.09
N/A
EPS
0.30
N/A
Revenue
$24,347,217.00
$103,069,000.00
Revenue This Year
$30.82
$23.34
Revenue Next Year
$20.84
$22.98
P/E Ratio
$30.87
N/A
Revenue Growth
29.34
21.68
52 Week Low
$5.76
$1.35
52 Week High
$10.54
$5.33

Technical Indicators

Market Signals
Indicator
CODA
MDXH
Relative Strength Index (RSI) 51.63 32.57
Support Level $8.86 $3.25
Resistance Level $9.58 $3.40
Average True Range (ATR) 0.40 0.17
MACD 0.07 0.00
Stochastic Oscillator 49.62 14.29

Price Performance

Historical Comparison
CODA
MDXH

About CODA Coda Octopus Group Inc.

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: